Results 161 to 170 of about 1,106,155 (263)

When to consider an inborn error of immunity: clues for physicians

open access: yesInternal Medicine Journal, Volume 56, Issue 9, Page 1488-1499, September 2026.
Abstract The term inborn errors of immunity (IEIs) refers to the rapidly expanding group of genetic disorders causing dysregulation of the immune system. With improved genetic testing in recent years, the number of defined IEIs and their range of phenotypic presentations has grown vastly, with more than 550 IEIs now described.
Meera Thangarajah, Lucinda J. Berglund
wiley   +1 more source

Management of a Complex Orbital Post-transplantation Lymphoproliferative Disorder: A Case Report and Literature Review. [PDF]

open access: yesIn Vivo
Maruyama T   +14 more
europepmc   +1 more source

Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 9, Page 1525-1534, September 2026.
Immunosuppressive disease was associated with reduced overall survival, while anticoagulant use was linked to prolonged progression‐free survival in advanced cutaneous squamous cell carcinoma treated with immune checkpoint inhibitors. Host‐related factors may modulate immunotherapy efficacy and warrant prospective validation.
Glenn Geidel   +27 more
wiley   +1 more source

Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Report of three cases. [PDF]

open access: yesAn Bras Dermatol
Vargas-Mora P   +5 more
europepmc   +1 more source

Multi‐omics profiling of chronic immune‐mediated skin diseases: SKINERGY protocol and strategic evaluation

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 9, Page 1490-1501, September 2026.
The SKINERGY study will investigate six immune‐mediated inflammatory skin diseases through a nationwide collaboration across all Dutch university medical centres. Involving 720 patients and 120 healthy volunteers, it is aimed at generating a high‐quality dataset to identify biomarkers that enable personalized treatment strategies and improved disease ...
N. G. Koster   +68 more
wiley   +1 more source

The IPTA Nashville Consensus Conference on Post‐Transplant Lymphoproliferative Disorders After Solid Organ Transplantation in Children: Updates on Classification and Prevention—2026

open access: yesPediatric Transplantation, Volume 30, Issue 9, September 2026.
ABSTRACT The 2019 International Pediatric Transplant Association (IPTA) consensus conference assessed available evidence and developed recommendations for various aspects of care relating to post‐transplant lymphoproliferative disorders (PTLD) after solid organ transplantation in children.
Michael Green   +7 more
wiley   +1 more source

The immunosuppressive tumor microenvironment in post-transplant lymphoproliferative disorder: pathogenesis and novel therapeutic frontiers. [PDF]

open access: yesFront Immunol
Dello Strologo A   +7 more
europepmc   +1 more source

Concurrent Howell–Jolly body‐like inclusions, Barr bodies and Döhle bodies in an immunosuppressed patient with sepsis

open access: yes
British Journal of Haematology, Volume 209, Issue 3, Page 870-871, September 2026.
Vandana Panakkal, Nana P. Matsumoto
wiley   +1 more source

Home - About - Disclaimer - Privacy